ROLE OF HORMONE RECEPTORS AND HER2 IMMUNOHISTOCHEMISTRY IN PREDICTING RESPONSE TONEOADJUVANT CHEMOTHERAPY IN BREAST CANCER. IJARR 2016, 1 (11), 22-26.